'Seek-and-destroy' Cancer Gene Therapy Highly Effective

Scientists have said that the "seek-and-destroy" cancer gene therapy is highly effective in the treatment of cancer.

During lab tests, the therapy by researchers at Strathclyde University in Glasgow resulted in 90 percent of skin cancer tumours disappearing altogether.

Liver an Excellent Target For Cancer Gene Therapy
A study demonstrates that cancer cells in the liver are excellent targets for gene therapy using adenoviral vectors.

The team is now investigating the technique's effectiveness at treating different forms of the disease.

Currently, most gene therapies cannot be delivered to tumours without harming surrounding healthy tissue.

The researchers, led by Dr Christine Dufes, accomplished this by using the plasma protein transferrin, which carries iron through the blood.

Cancer Warning on Cell Phones Proposed
It is unsure whether cell phones cause cancer is still going on, with some groups saying that a safety-warning label should be put on them the way they are put on cigarettes and alcohol.

Carrier proteins for transferrin are often found in large amounts in cancers.

During initial tests on skin cancer cells, the researchers found that the treatment led to a rapid and sustained regression of the tumours over one month, without any apparent signs of toxicity.

Caucasian Cancer Resistance To Statins Traced To Gene Variant
The cholesterol drug statin could protect many against colorectal cancer too, but Caucasians are out of its reach. A gene variant in them somehow renders them impervious to statin effect.

In 90 percent of cases, the tumours completely disappeared.

"This therapeutic system gave very promising results on cancer treatment in the initial tests we have done," the BBC quoted Dufes as saying.

How the Weather Up in the North may Up Prostate Cancer Risk
A new research by scientists at Idaho State University has indicated the link between the grim weather in the North and increase in prostate cancer cases in men.

"To be able to make tumours not just shrink but vanish is a great breakthrough for us, particularly as there's currently no gene therapy of this kind on the market for intravenous administration.

"We have so far tested this seek-and-destroy system in laboratory settings on just one type of cancer - skin cancer- but are currently investigating its efficacy in different cancer models," she added.

The research has been published in the latest edition of the Journal of Controlled Release.

Source-ANI
SAV